EarlySight

EarlySight is a Swiss medical technology company specializing in high-resolution retinal imaging to enable early detection and monitoring of eye diseases. A spin-off from EPFL, the company utilizes proprietary adaptive optics technology to observe the retina at a cellular level, specifically targeting the retinal pigment epithelium and photoreceptors. Their flagship imaging system provides clinicians with unprecedented detail, aiming to identify pathological changes long before they are visible with standard diagnostic tools. By focusing on early-stage biomarkers for conditions like age-related macular degeneration and glaucoma, EarlySight supports the development of new treatments and improves patient outcomes through timely intervention.